Yves Duroseau, MD
Emergency Medicine · New York, NYNPI 1629094289
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Novartis accounts for 98.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $42,860 and has fallen 99.6% since, to $151 in 2025. Among emergency medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $785.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$43K
- Abbott$172
- BTG International Inc.$151
- Medtronic$89
- Misonix Inc$70
- AstraZeneca$22
What the payments were for
- Consulting fees$9,37121%
- Speaking & faculty fees$22,10850%
- Travel & lodging$10,75024%
- Food & beverage$1,7464%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 51 | $43,471 |
| Abbott | 1 | $172 |
| BTG International Inc. | 1 | $151 |
| Medtronic | 1 | $89 |
| Misonix Inc | 1 | $70 |
| AstraZeneca | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$43,975 in reported general payments places this provider in the 95th percentile of 4,167 emergency medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PaxlovidNirmatrelvir/Ritonavir | 16 | $1,429 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $272 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $232 |
| Fluticasone Propionate | 17 | $152 |
| Mupirocin | 16 | $97 |
| Doxycycline Hyclate | 14 | $69 |
| Ibuprofen | 12 | $48 |
| Azithromycin | 17 | $43 |
| Prednisone | 29 | $20 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in New York
- Joseph HabbousheNew York$309K
- Sohan ParekhNew York$174K
- Benjamin AbellaNew York$143K
- Leroy NicklesNew York$64K
- Bret NelsonNew York$58K
- Patrick MaherNew York$20K
- Andy JagodaNew York$18K
- Jonathan St GeorgeNew York$13K
- Steven KaplanNew York$13K
- Sonya StokesNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.